Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Buy
Category: ETFs
Launch Date: 05-07-2021
Asset Class:
Benchmark: NIFTY Pharma TRI
Expense Ratio: 0.0% As on (30-04-2025)
Status: Open Ended Schemes for subscription
Minimum Investment: 1000.0
Minimum Topup: 0.0
Total Assets: 85.64 Cr As on (31-03-2025)
Turn over: 45
NAV as on 06-05-2025

21.9796

-0.25 (-1.1215%)

CAGR Since Inception

11.64%

NIFTY Pharma TRI 14.44%

PERFORMANCE of Nippon India Nifty Pharma ETF

Scheme Performance (%) Data as on - 06-05-2025

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
Nippon India Nifty Pharma ETF 12.57 19.49 - - 11.64
Nifty Pharma TRI 12.87 19.78 19.29 6.7 14.44
ETFs 9.6 16.67 21.5 12.5 11.33

Yearly Performance (%)

Nav Movement

Fund Managers

Himanshu Mange

Investment Objective

The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.

RETURNS CALCULATOR for Nippon India Nifty Pharma ETF

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of Nippon India Nifty Pharma ETF

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
Nippon India Nifty Pharma ETF 12.37 - -
ETFs - - - - - -

PEER COMPARISION of Nippon India Nifty Pharma ETF

Period
Data as on - 06-05-2025
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
Nippon India Nifty Pharma ETF 05-07-2021 12.57 31.18 19.49 0.0 0.0
Axis Gold ETF 10-11-2010 35.19 24.75 22.41 14.82 12.29
Invesco India Gold Exchange Traded Fund 12-03-2010 35.01 24.62 22.51 14.88 12.65
LIC MF Gold Exchange Traded Fund 09-11-2011 34.59 24.52 22.67 15.0 12.82
Tata Gold Exchange Traded Fund 12-01-2024 34.2 0.0 0.0 0.0 0.0
ICICI Prudential Gold ETF 05-08-2010 33.92 24.35 22.39 14.75 12.44
Aditya Birla Sun Life Gold ETF 13-05-2011 33.83 24.39 22.3 14.66 12.58
Mirae Asset Hang Seng TECH ETF 06-12-2021 33.76 18.84 13.23 0.0 0.0
Zerodha Gold ETF 03-02-2024 33.76 0.0 0.0 0.0 0.0
Mirae Asset Gold ETF 20-02-2023 33.75 24.57 0.0 0.0 0.0

PORTFOLIO ANALYSIS of Nippon India Nifty Pharma ETF

Asset Allocation (%)

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Mf Online Inc (with ARN code 160300) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.

BSE
Member Code: 32262
AMFI
ARN: 160300